Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Fine & Speciality Chemicals
Return to: PBR Home | Production & Manufacturing | Fine & Speciality Chemicals | Suppliers

Almac Group – Partnering to Advance Human Health Case Studies

Almac Group – Partnering to Advance Human Health

Almac Presents selectAZymeTM for Effective Biocatalysis Solutions Almac’s biocatalysis expertise ranges from enzyme discovery, evolution and enzyme production to the synthesis of complex chiral intermediates and active ingredients, all based on selectAZymeTM technology.
Read case study
Almac's Paediatric Drug Product: Development Through to Commercialisation Almac, in partnership with a US Biotech client and supported by Merz, a world leader in the design and fabrication of stickpack sachet machines has developed a flexible paediatric dosage form consisting of minitablets filled into stickpacks using a robust manufacturing and filling process suitable for routine commercial manufacture.
Read case study
Capital Partnerships: Planning for Long-Term Success, by Almac With significant capital investment in equipment and extensive associated facility modifications, Almac successfully transferred and scaled-up Ironwood Pharmaceuticals’ innovative yet challenging orally delivered peptide product, linaclotide, helping them prepare to meet global demand in multiple territories.
Read case study
Almac Asks: Are you Equipped with an Inspection Ready IRT? In the race to improve speed and efficiency in drug development, clinical research studies have grown dramatically in the last decade in both numbers and complexity.
Read case study
Case Study: Supplying Costly Investigational Product: Pre-Randomisation Approach Reduces Drug Wastage Certainly, every sponsor wants to minimise wastage in clinical trial supplies, but the motivation to do so is extraordinary when the product under study is unusually expensive. A top-tier, international pharmaceutical company engaged Almac to ensure that it did not incur undue drug supply costs for a global study involving a very expensive investigational product. With some ingenuity and customisations to the IXRS® platform for managing patients, supplies, and trial data, Almac helped the client re-envision its study design and supply strategy.
Read case study
Case Study: Top 20 Global Pharma Company Makes Cost Savings of Almost $5M Top 20 global pharma company makes cost savings of almost $5million per year in Phase III study from utilising Almac's Supply Chain Management expertise mid-trial.
Read case study